Barrou BARROU

Prof. Barrou BARROU

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Clinics and Research in Hepatology and Gastroenterology
Verified
Journal Article
Closed access
AMAlessandra Mazzola
Alessandra Mazzola
RBRaffaele Brustia
Raffaele Brustia
BMBianca Magro
Bianca Magro
MAMuhammad Atif
Muhammad Atif
NONassera Ouali
Nassera Ouali
FCFilomena Conti
Filomena Conti

14 October 2023 in Chest
Verified
Journal Article
Closed access
GTGuillaume Thizy
Guillaume Thizy
AFAdrien Flahault
Adrien Flahault
ASAnne Scemla
Anne Scemla
OROlivier Roux
Olivier Roux
SJSophie Jarraud
Sophie Jarraud
ELEMMANUEL Lafont
EMMANUEL Lafont

1 August 2021 in Nephrologie & Therapeutique
Verified
Journal Article
Closed access
LCLionel Couzi
Lionel Couzi
MMMiriam Manook
Miriam Manook
SCSophie Caillard
Sophie Caillard
ÉÉÉric Épailly
Éric Épailly
BBBarrou BARROU
Barrou BARROU
MHMarc Hazzan
Marc Hazzan
The first wave of the Covid-19 pandemic resulted in a drastic reduction in kidney transplantation and a profound change in transplant care in France. It is critical for kidney transplant centers to understand the behaviors, concerns and wishes of transplant recipients and waiting list candidates. French kidney patients were contacted to answer an online electronic survey at the end of the lockdown. At the end of the first wave of the pandemic in France (11 May 2020), 2112 kidney transplant recipients and 487 candidates answered the survey. More candidates than recipients left their home during the lockdown, mainly for health care (80.1% vs. 69.4%; P < 0.001). More candidates than recipients reported being exposed to Covid-19 patients (2.7% vs. 1.2%; P = 0.006). Many recipients and even more candidates felt inadequately informed by their transplant center during the pandemic (19.6% vs. 54%; P < 0.001). Among candidates, 71.1% preferred to undergo transplant as soon as possible, 19.5% preferred to wait until Covid-19 had left their community, and 9.4% were not sure what to do. During the Covid-19 pandemic in France, the majority of candidates wished to receive a transplant as soon as possible without waiting until Covid-19 had left their community. Communication between kidney transplant centers and patients must be improved to better understand and serve patients’ needs.

Verified
Journal Article
Open access
PDF file
LELeize-Zal Elisabeth
Leize-Zal Elisabeth
LDLeïla Demini
Leïla Demini
BBBarrou BARROU
Barrou BARROU
FZFranck Zal
Franck Zal
Hemoglobin-based oxygen carriers have been developed to compensate the needs of blood for transfusions. Most of them were based on intracellular hemoglobin extracted from bovine or human blood, but unfortunately, this type of hemoglobin did not pass through the last steps of clinical trials. In this context, HEMARINA discovered a natural extracellular hemoglobin, possessing several advantages avoiding intracellular hemoglobin-related side effects. Many preclinical studies assessed the safety of M101 used in intravenous (IV) injection in rodents. To explore the safety of IV injections of M101 in large mammals, six dogs received each a single injection of liquid M101 according to a dose escalation with a 48 h follow-up. Then, two monkeys received multiple IV injections of the same dose of M101 every hour for seven hours. This study showed that single and multiple IV injections in dogs and monkeys did not cause clinical or histological lesions, nor did they induce immunological reactions. This makes M101 the best candidate to date for human use in emergency situations requiring blood and, in several diseases, causing hypoxia problems.

6 January 2025 in Drug Testing and Analysis
Verified
Journal Article
Closed access
BBBarrou BARROU
Barrou BARROU
ELElisabeth Leize‐Zal
Elisabeth Leize‐Zal
FZFranck Zal
Franck Zal

1 February 1993 in La Revue de Médecine Interne
Verified
Journal Article
Closed access
GCG. Coutant
G. Coutant
JRJ.P. Robin
J.P. Robin
PSP. De Saint-Maur
P. De Saint-Maur
BBBarrou BARROU
Barrou BARROU
ADA. Delcourt
A. Delcourt
PGP. Godeau
P. Godeau